H2020 support to SMEs in 2017
In 2017, €437.5 mio of a financial support is available support to SMEs with innovative business idea at European or global scale. For that purpose 13 topics were identified by the European Commission. Proposals can be submitted for:
Phase 1. Concept & Feasibility Assessment
Idea to concept (6 months). The European Union will provide €50 000 in funding, and carry out a feasibility study to verify the viability of the proposed disruptive innovation or concept. The SME will draft an initial business proposal (around 10 pages).
Phase 2. Demonstration, Market Replication, R&D
Concept to Market-Maturity (1-2 years) Assisted by the EU, the SME will further develop its proposal through innovation activities, such as demonstration, testing, piloting, scaling up, and miniaturisation. It will also draft a more developed business plan (around 30 pages). Proposals will be based on a business plan developed on phase 1 or otherwise. The EU aims to contribute between €0.5 million and €2.5 million.
Phase 3. Commercialisation
Prepare for Market Launch. SMEs will receive extensive support, training, mentorship and facilitating access to risk finance as the project is further polished into a marketable product.
The deadlines for submission of applications in 2017 are:
Phase 1: 15 February, 3 May, 6 September, 8 November
Phase 2: 18 January, 6 April, 1 June, 18 October
In developing innovative ideas and strategies, AMIRES can be of your help with our vast experience in this programme and expertise in SME coaching.
*Submission of proposals into Phase one SMEInst-05 Supporting innovative SMEs in the healthcare biotechnology sector is no longer possible.
BIOPRINTING – Engineering Complex Bioarchitectures to Biomimic Nature: A Step Closer To The Development of Artificial Organs06/10/2017In the webinar, regenHU’s cutting edge biofabrication process, which creates infinite possibilities in the manufacture of artificial tissues and organs, was presented. …
21/09/2017In his presentation, Dr. Fyček provided an overview of opportunities for funding of regenerative medicine projects from the upcoming Horizon …
31/07/2017In his presentation, prof. Simon shared achievements of his group’s research on organic electronics and their animal and mammalian applications, …
29/06/2017In his presentation, prof. Adam outlined the possibilities for utilization of selenium nanoparticles and shared some latest research achievements on …
04/05/2017In their presentation, prof. Focarete and prof. Calzà introduced activities of the Health Sciences and Technologies—Interdepartmental Center for Industrial Research …
16/03/2017Brief introduction of Enantis and its R&D activities was followed by information about current and future use of growth factors (mainly …
29/11/2016In their presentation, Drs. Pokorný and Kontková:
Introduced research development activities at CONTIPRO (click HERE for more information);
Provided information about their unique 4SPIN® technologies (i.e. electrospinning, electrospraying, …
04/10/2016In his presentation, Prof. Santin introduced the lysine-based biomimetic dendrons synthesis as a platform for extracellular matrix analogue. He covered …
22/09/2016This second event titled „Intervertebral disc regeneration assisted by collagen nanostructures“ and led by professor Prof. Hans Jörg Meisel introduced a new …
23/08/2016During the event titled „Polymeric Nanocapsules as tools to face challenges in Regenerative Medicine„, Dr. Gemma Vilar Palos, senior researcher in the Human …
21/ 03 / 2017Working Group Nanotechnologies for Regenerative Medicine (WG RegMed) of the European Technology Platform for Nanomedicine (ETPN) in partnership with AMIRES launched …